The Spectranetics Corporation Product Pipeline Analysis
Global Markets Direct, January 2009, Pages: 24
The Spectranetics Corporation Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.
1
1 2
1.1 List Of Tables 4
1.2 List of Figures 5
2 Company Overview 6
2.1 Key Information 6
2.2 Industry Outlook - Cardiovascular Devices 6
3 The Spectranetics Corporation Pipeline Products 7
3.1 The Spectranetics Corporation Product Pipeline Analysis 7
3.1.1 The Spectranetics Corporation Pipeline Products By Equipment Type 7
3.1.2 The Spectranetics Corporation Pipeline Products By Development Stage 7
3.1.3 The Spectranetics Corporation Pipeline Products By Therapy Area 7
3.1.4 The Spectranetics Corporation Pipeline Products By Clinical Trials 7
3.1.5 The Spectranetics Corporation Pipeline Products By News Summary 8
3.2 Spectranetics Laser Sheath (SLS II) 8
3.2.1 Product Status 8
3.2.2 Product Description 8
3.2.3 Product Milestone 8
3.2.4 Clinical Trials 10
3.3 Lead Locking Device 10
3.3.1 Product Status 10
3.3.2 Product Description 10
3.3.3 Product Patent Details 11
3.4 CLiRpath Turbo excimer laser catheter 12
3.4.1 Product Status 12
3.4.2 Product Description 12
3.4.3 Clinical Trials 12
3.4.4 Product Patent Details 15
4 Recent Developments 16
4.1 Product News 16
4.1.1 Jun 05, 2008: Spectranetics Enrolls First Patients In TAAMI Trial 16
4.1.2 May 12, 2008: Spectranetics Laser System Successfully Assists Removal Of 975 Cardiac Leads 16
4.1.3 Feb 25, 2008: First Patient Enrolled In Study Evaluating Performance Of Spectranetics Laser Ablation 17
4.1.4 Jul 29, 1997: Spectranetics Laser Sheath For Removing Pacemaker Leads Unanimously Recommended By Fda Advisory Committee 18
4.2 Clinical Trials 19
4.2.1 Jun 05, 2008: Spectranetics Enrolls First Patients In TAAMI Trial 19
4.2.2 May 12, 2008: Spectranetics Laser System Successfully Assists Removal Of 975 Cardiac Leads 20
4.2.3 Feb 25, 2008: First Patient Enrolled In Study Evaluating Performance Of Spectranetics Laser Ablation 20
5 Appendix 22
5.1 Methodology 22
5.1.1 Coverage 22
5.1.2 Secondary Research 23
5.1.3 Primary Research 23
5.1.4 Expert Panel Validation 24
5.2 Contact Us 24
5.3 About us24
5.4 Disclaimer 24
Executive Summary
1.2 List of Figures
Figure 1: Global Markets Direct Methodology 22
The following companies are the major competitors of The Spectranetics Corporation:
Boston Scientific Corporation
Cordis Corporation
Foxhollow Technologies, Inc.
Medtronics, Inc.
Possis Medical, Inc.
St Jude Medical, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network